Page last updated: 2024-11-05

tricarballylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tricarballylic acid, also known as 1,2,3-propanetricarboxylic acid, is a tricarboxylic acid. It is a white solid that is soluble in water and ethanol. Tricarballylic acid is found naturally in some plants and animals. It is also a product of the oxidation of citric acid. Tricarballylic acid is used as a starting material for the synthesis of other organic compounds. It is also used as an intermediate in the production of pharmaceuticals and pesticides. The acid is a key intermediate in the biosynthesis of various natural products, such as the antibiotic tetracycline. Studies have shown that tricarballylic acid has potential applications in the pharmaceutical industry, such as its use in the treatment of diabetes and cancer. Further research is ongoing to explore the potential therapeutic uses of this compound. Tricarballylic acid is a useful chemical in the production of certain polymers and resins. It can also be used as a catalyst in certain chemical reactions. Tricarballylic acid is a compound of interest in the field of biogeochemistry. It has been found to play a role in the cycling of carbon in the environment. Research is ongoing to understand the role of tricarballylic acid in the carbon cycle.'

tricarballylic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

tricarballylic acid : A tricarboxylic acid that is glutaric acid in which one of the beta-hydrogens is substituted by a carboxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID14925
CHEMBL ID1236394
CHEBI ID45969
SCHEMBL ID34866
MeSH IDM0090614

Synonyms (67)

Synonym
CHEMBL1236394
.beta.-carboxyglutaric acid
propane-1,3-tricarboxylic acid
nsc-2347
carballylic acid
tricarballylic acid
propane 1,3-tricarboxylic acid
nsc2347 ,
99-14-9
1,3-propanetricarboxylic acid
NCI60_001896
1,2,3-propanetricarboxylic acid
propane-1,2,3-tricarboxylic acid
1,2,3-tripropanetricarboxylic acid
NCGC00013020
inchi=1/c6h8o6/c7-4(8)1-3(6(11)12)2-5(9)10/h3h,1-2h2,(h,7,8)(h,9,10)(h,11,12
TRC ,
tricarballylic acid, 99%
DB04562
3-carboxyglutaric acid
carboxymethylsuccinic acid
3-carboxypentanedioic acid
beta-carboxyglutaric acid
AI-942/42301799
NCI2347
NCISTRUC1_000003
NCISTRUC2_000057
NCGC00096147-01
propane 1,2,3-tricarboxylic acid
AKOS000277372
bdbm50119563
chebi:45969 ,
P0490
propane-1,2,3-tricarboxylate;1,2,3-propanetricarboxylic acid
A845967
ra5qh2j020 ,
einecs 202-733-3
ai3-52246
nsc 2347
unii-ra5qh2j020
C19806
CCG-37950
NCGC00013020-02
propane tricarboxylic acid
FT-0606218
S6286
BRD-K22081896-001-01-4
1,2,3-propanetricarboxylicacid
SCHEMBL34866
tricarballylic acid [mi]
1,2,3-tricarboxypropane
propane tricarboxylic acid [inci]
DTXSID8059186
1,2,3-propane tricarboxylic acid
mfcd00002723
Q2823313
SY049169
STL573301
AS-10539
EN300-112188
b-carboxyglutaric acid
H10777
CS-0039229
HY-W020215
propane-1,2,3-tricarboxylicacid
tricarballylicacid
Z1255419161

Research Excerpts

Overview

Tricarballylic acid is a non-metabolizable rumen bacterial fermentation product of tricarboxylic acid trans-aconitic acid.

ExcerptReferenceRelevance
"Tricarballylic acid is a non-metabolizable rumen bacterial fermentation product of the naturally occurring tricarboxylic acid trans-aconitic acid. "( Transport of tricarballylate by intestinal brush-border membrane vesicles from steers.
Scharrer, E; Wolffram, S; Zimmermann, W, 1993
)
1.73
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tricarboxylic acidAn oxoacid containing three carboxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (8)

Processvia Protein(s)Taxonomy
L-serine metabolic processSerine racemaseHomo sapiens (human)
serine family amino acid metabolic processSerine racemaseHomo sapiens (human)
response to xenobiotic stimulusSerine racemaseHomo sapiens (human)
response to organic cyclic compoundSerine racemaseHomo sapiens (human)
response to lipopolysaccharideSerine racemaseHomo sapiens (human)
pyruvate biosynthetic processSerine racemaseHomo sapiens (human)
D-serine metabolic processSerine racemaseHomo sapiens (human)
D-serine biosynthetic processSerine racemaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (13)

Processvia Protein(s)Taxonomy
magnesium ion bindingSerine racemaseHomo sapiens (human)
L-serine ammonia-lyase activitySerine racemaseHomo sapiens (human)
calcium ion bindingSerine racemaseHomo sapiens (human)
protein bindingSerine racemaseHomo sapiens (human)
ATP bindingSerine racemaseHomo sapiens (human)
D-serine ammonia-lyase activitySerine racemaseHomo sapiens (human)
glycine bindingSerine racemaseHomo sapiens (human)
threonine racemase activitySerine racemaseHomo sapiens (human)
PDZ domain bindingSerine racemaseHomo sapiens (human)
pyridoxal phosphate bindingSerine racemaseHomo sapiens (human)
serine racemase activitySerine racemaseHomo sapiens (human)
identical protein bindingSerine racemaseHomo sapiens (human)
protein homodimerization activitySerine racemaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
cytoplasmSerine racemaseHomo sapiens (human)
cytosolSerine racemaseHomo sapiens (human)
neuronal cell bodySerine racemaseHomo sapiens (human)
apical part of cellSerine racemaseHomo sapiens (human)
cytoplasmSerine racemaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
AID1246860Inhibition of hexa-His-tagged purified human recombinant serine racemase expressed in Escherichia coli BL21 Codonplus (DE3)-RIL cells assessed as reduction in beta-elimination of L-serine at 2.8 mM by spectrophotomtery2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Expanding the chemical space of human serine racemase inhibitors.
AID1246863Inhibition of hexa-His-tagged purified human recombinant serine racemase expressed in Escherichia coli BL21 Codonplus (DE3)-RIL cells assessed as reduction in beta-elimination of L-serine at by spectrophotomtery2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Expanding the chemical space of human serine racemase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (41)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (19.51)18.7374
1990's9 (21.95)18.2507
2000's15 (36.59)29.6817
2010's9 (21.95)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 96.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index96.14 (24.57)
Research Supply Index3.74 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index168.42 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (96.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other41 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]